Advertisement

Drugs

, Volume 45, Supplement 3, pp 225–226 | Cite as

Clinical Trial of Sparfloxacin in the Treatment of Leprosy

  • Scott G. Franzblau
  • Gertrude P. Chan
Poster Presentations Quinolone Activity against Intracellular Pathogens Including Mycobacteria

Keywords

Ofloxacin Leprosy Baton Rouge Pefloxacin Sparfloxacin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Franzblau SG, Biswas AN, Jenner P, Colston MJ. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents. Leprosy Review 63: 125–133, 1992PubMedGoogle Scholar
  2. Franzblau SG, White KE. Comparative in vitro activity of 20 fluoroquinolones against Mycobacterium leprae. Antimicrobial Agents and Chemotherapy 34: 229–231, 1990PubMedCrossRefGoogle Scholar
  3. Grosset JH, Guelpa-Lauras CC, Perani EG, N’Deli LN. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. International Journal of Leprosy 58: 281–295, 1990Google Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • Scott G. Franzblau
    • 1
  • Gertrude P. Chan
    • 2
  1. 1.GWL Hansen’s Disease Laboratory Research BranchBaton RougeUSA
  2. 2.Research Institute for Tropical MedicineMetro ManilaPhilippines

Personalised recommendations